Growth opportunities Customer focus on recombinant protein solutions across life sciences, food, nutrition, and bioindustrial markets indicates cross-sell potential for their C1 expression system and animal-free proteins to adjacent sectors and expanded product lines.

Industrial enzyme expansion Recent launch of a proprietary industrial enzyme program for advanced cellulose processing creates a sales avenue with cellulose-based bioprocessing, paper and biofuel industries, and potential OEM partnerships.

Strategic partnerships OEM distribution and collaborations with IBT Bioservices and Inzymes ApS demonstrate a channel-friendly approach; leverage these relationships to accelerate multi-region adoption and co-developed products.

Non-animal product growth Multiple animal-free protein product launches and planned non-animal dairy enzymes suggest expanding demand for sustainable, animal-free bioproducts; target food tech, nutrition, and life sciences customers seeking compliant supply chains.

Global footprint Expansion of operations in Japan and Eastern Asia coupled with international partnerships presents opportunities to address regional R&D labs, contract manufacturers, and distribution networks for faster market penetration.